A New Era In Incontinence Treatments

Join us at our AUGS lunch symposium to learn how innovation has fostered a new era of highly effective treatments that benefit your incontinence patients, whether they suffer from overactive bladder, fecal incontinence, stress urinary incontinence, or even mixed incontinence.

Thursday, October 14 at 12:30PM MT

Mickey Karram, MD Christ Hospital
Cincinnati, OH

Kimberly Kenton, MD Northwestern Medicine
Chicago, IL

Andrea Pezzella, MD Southern Urogynecology
West Columbia, SC

www.Axonics.com

Results and experiences may vary and are unique to each patient. No promise or guarantee is made about specific results or experiences.

References:

Important Safety Information:
Indications: Axonics SNM Therapy for urinary control is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments. Axonics SNM Therapy for bowel control is indicated for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments.

Contraindications: The Axonics SNM System is contraindicated for patients who have not demonstrated an appropriate response to test stimulation; or Patients who are unable to operate the Axonics SNM System.

Warnings: Axonics SNM Therapy is not intended for patients with urinary mechanical obstructions. Diathermy cannot be performed on patients implanted with the Axonics SNM System. The Axonics SNM System is a MRI Conditional system. The following procedures may adversely affect the patient or the Axonics SNM System including: Lithotripsy, Monopolar electro surgery, Microwave and Radiofrequency (RF) ablation, Radiation therapy over the Neurostimulator, and Ultrasound or scanning equipment. Electromagnetic interference can interfere with the function of the Axonics SNM System. Walkthrough metal detectors, security archways, hand-held security wands should not affect the stimulator. Full-body security scanners are considered safe in patients that have the stimulator. Patients should minimize their exposure by not lingering in the immediate area of security systems. The Neurostimulator, Remote Control and Charger contain batteries with chemicals that can cause bodily harm, including severe burns, if exposed to your body. Do not rupture or pierce the devices or use the device that appears damaged or has visible internal components. If swelling or redness occurs near the Charger attachment site, discontinue to the use of Charger and consult your doctor before using the Charger again.

Precautions: The safety and effectiveness of the therapy has not been established for use in pregnant women, the unborn fetus, and during delivery, for pediatric patients (under the age of 18 years for FI and under the age of 16 years for OAB and UR), for patients with neurological disease origins, such as multiple sclerosis or diabetes, or for bilateral stimulation.

Caution: Federal law (USA) restricts this device to sale by, or on the order of, a physician.